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Traditional Japanese herbal
medicines for treatment of
odontopathy
Kojiro Yamaguchi *
Oral and Maxillofacial Surgery, Kagoshima University Hospital, Kagoshima, Japan
This article highlights several refractory oral diseases, such as stomatitis, burning mouth
syndrome (BMS), glossalgia, atypical facial pain (AFP), oral cancer, dry mouth, and
Sjögren’s syndrome (SJS), in which use of Japanese herbal medicines, Kampomedicines
(KM), on the basis of Kampo theory could exert the maximum effects on human body. (1)
In acute stomatitis, heat because of agitated vital energy may affect the head, chest,
and middle abdominal region. Stomatitis is also related to the generation of reactive
oxygen species (ROS). There are many antioxidants in the crude extracts of KM. Thus,
we can control environmental factors (cold, heat, dampness, dryness) and vital energy,
blood, and fluid of the organ systemically using KM to treat stomatitis and eliminate local
ROS accumulation. (2) BMS, glossalgia, and AFP are multifactorial syndromes involving
the interaction of biological and psychological factors. Local temperature decrease and
edema often occur in chronic pain. These are local circulatory disturbances that can be
resolved by improving the flow of blood and fluid. Several KM, such as Tokishakuyakusan
and Kamishoyosan (KSS), are effective for enhancing peripheral circulation. Those such
as Saikokaryukotuboreito, Yokukansan, KSS, and Saibokutou can reduce stress and
associated pain by altering glutamatergic and monoaminergic transmission in the brain.
The clinical efficacy of KM for BMS and AFP may depend on the regulation of the
mesolimbic dopaminergic and descending glutamatergic pain modulation systems. (3)
Regarding oral cancer treatment, I introduce four possible applications of KM, inhibition of
the proliferation of cancer cells, complementation of themain cancer therapy, reduction of
side effect caused by themain anti-cancer therapy and improvement of quality of life such
as the overall status and/or oral discomfort. This review explains in more details Hozai
such as Hochuekkito (HET), Juzendaihoto, and Ninjinyoeito (NYT) that are frequently used
to improve both immunosuppression and deficiencies of Ki, Ketsu, and Sui in oral cancer
patients. (4) Heat- and cold-dryness stages exist in dry mouth and SJS. Byakkokaninjinto
is useful for heat-dryness, while NYT, Bakumondoto, and HET have moisturizing effects
in the cold-dryness stage. Thus, Kampo therapy is useful for many oral diseases that
cannot be cured by western medicine.
Keywords: Kampo therapy, stomatitis, glossalgia, oral cancer, dry mouth
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Introduction
The human oral cavity is an anatomically complex structure
that has evolved to perform a multitude of functions, including
mastication, swallowing, tasting, and articulation. The oral
cavity is also the initial digestive organ, and thus critical for
nutrition and gastrointestinal function. These functions require
an extensive and highly integrated system of sensorimotor
control pathways. Thus, oral sensation and function are sensitive
to local stimuli, oral disease, general health status, systemic
disease, resident microorganisms, and even psychological and
emotional states. Systems of traditional medicine treat oral
discomfort and odontopathy not only by considering anatomical
and intraoral environmental factors (i.e., cold, heat, dampness,
and dryness), but from a holistic perspective considering general
physical and psychological health. Kampo theory, a branch
of traditional Japanese medicine emphasizing the treatment of
vital energy (Ki), blood, and fluid abnormalities using herbal
preparations, has proven to be highly effective for the treatment
of oral discomfort, resulting from various diseases. The Japanese
traditional herbal formulae, known as Kampo, have gradually
re-emerged, and approximately 20–30 different formulations
(mainly herbal extracts) can be prescribed for treatment of
odontopathy.
The objective of this article is to introduce and summarize
pharmacological actions and clinical applications of Japanese
herbal medicines in various refractory oral diseases such as
stomatitis (Section Stomatitis), burning mouth syndrome (BMS),
glossalgia (glossodynia), atypical facial pain (AFP) [Section
Burning Mouth Syndrome (BMS), Glossalgia (Glossodynia), and
Atypical Facial Pain (AFP)], oral cancer (Section Oral Cancer),
dry mouth, and Sjögren’s syndrome (SJS) (Section Dry Mouth
and Sjögren’s Syndrome). The literature search used Evidence
Reports of Kampo Treatment 2010: 345 Randomized Controlled
Trials (EKAT 2010) (Okabe and Tsutani, 2010) and EBM of
Kampo Medicine in Oral Surgery (2015) (Wang et al., 2015).
Furthermore, Pubmed and ICHUSHI [Japan Medical Abstracts
Society (Jamas)] were used as search engines. This article includes
63 reports.
Ijima et al. reported the clinical usefulness of Kampo for
the treatment of intractable oral diseases such as dry mouth,
glossodynia, feeding and swallowing disorders, and intractable
stomatitis in 35 medically compromised patients (5 male and 30
female) (Ijima et al., 2007).
Kampo medicines (KM) controlled 20 cases, with complete
alleviation of symptoms (57.1%), while 14 cases showed
improvement (40.0%). Overall, Kampo treatment was extremely
useful in 28 cases (80.0%) and considerably useful in three cases
(8.6%).
Ara et al. conducted a series of experiments testing the
efficacy of Kampo herbal medicines on periodontal disease,
drug-induced gingival overgrowth, and xerostomia (dry mouth)
using in vitro cultures and animal models. Shosaikoto (SST),
a formula containing a variety of bioactive flavones, saponins,
and gingerols, decreased lipopolysaccharide (LPS)-induced
prostaglandin E2 (PGE2) production by gingival fibroblasts;
this is consistent with anti-inflammatory activity in periodontal
tissues. In addition, Saireito inhibited the proliferation of gingival
fibroblasts in response to the calcium channel blocker nifedipine
(among several drug classes associated with gingival hyperplasia,
including anticonvulsants) and was effective against idiopathic
retroperitoneal fibrosis (Ara et al., 2010). In addition, both
the Byakkokaninjinto (BNT) and Goreisan (GRS) formulae
enhanced saliva secretion to mitigate xerostomia, which is
commonly associated with diabetes, in the streptozotocin-
induced diabetic mouse model. Horie et al. demonstrated
that Rikkosan (RKS) reduced PGE2 by selectively inhibiting
cyclooxygenase-2 (COX-2) activity in LPS-stimulated mouse
macrophage-like RAW264.7 cells (Horie et al., 2008).
Oral candidiasis (thrush), which often occurs in denture
wearers and people with systemic immunosuppression, manifests
with similar symptoms (such as oral bitterness, glossalgia,
stomatitis-like symptoms, and oral dryness).
Then the treatment of oral candidiasis is usually used anti-
fungal medicines, therefore, it should be ruled out beforehand.
If those symptoms remain even that have treated candidasis,
they are candidates for Kampo therapy.
Stomatitis
Kampo formulae are effective for treating oral diseases such as
stomatitis and oral lichen planus (Zheng et al., 2011). Stomatitis
presents with inflammatory manifestations including reddening,
erosion, and ulceration of the oral mucosa. Stomatitis may
occasionally be multiple or recurrent. In Kampo medicine,
stomatitis treatment differs depending on whether the symptoms
are intense acute or chronic. In the acute type, heat due to agitated
vital energy may affect the head, chest, and middle abdominal
region. Therefore, treatment is required to cool the heat in the
heart, stomach, and liver using formulae with cooling effects such
as Hangeshashinto (HST), Orento (ORT), Orengedokuto (OGT),
or BNT.
In the chronic type, prolonged head, chest, and middle
abdominal heat causes fluid deficiency. Therefore, formulae are
required not only to alleviate the heat but also to treat vital energy
and blood, and to increase wetness by increasing fluid retention.
In this case, the following formulations are often selected for
specific symptoms: (1) middle abdominal region deficiency-
treating formulae such as the Kenchuto group; (2) Rokumigan
and Hachimijiogan; (3) vital energy deficiency formulae such as
Hochuekkito (HET) and Rikkunshito (RKT); (4) dual deficiency-
treating formulae such as Juzentaihoto (JTT) and Ninjinyoeito
(NYT); and (5) other formulations such as Jiinkokato, Unseiin,
and Tokishakuyakusan (TSS).
Kampo formulae may also suppress the underlying causes of
stomatitis, particularly infection, inflammation, and concomitant
oxidative stress and drug induced type.
Scutellariae Radix, Coptidis Rhizoma, Cinnamomi Cortex,
Glycyrrhizae Radix, Astragali Radix, and Phellodendri Cortex
inhibited several bacterial infection.
Scutellariae Radix, Cinnamomi Cortex, Anemarrhenae
Rhizome, and Menthae Herba had antifungal effect. These crude
drugs were included in HST, ORT, NYT, HET, JTT, BNT, and
Kamishoyosan (KSS).
Frontiers in Pharmacology | www.frontiersin.org 2 August 2015 | Volume 6 | Article 176
Yamaguchi Japanese herbal medicines and odontopathy
And Glycyrrhizae Radix and Scutellariae Radix inhibited viral
infection (Toriizuka, 2003).
Li et al. found that procyanidin B1 purified from Cinnamomi
cortex inhibited infection by vesicular stomatitis virus and
suppresses hepatitis C virus replication (Li et al., 2010).
Astragali Radix, Scutellariae Radix, Phellodendri Cortex,
Coptidis Rhizoma, Glycyrrhizae Radix, Platycodi Radix,
Bupleuri Radix, Paeoniae Radix, Atractylodis Lanceae Rhizoma,
Cimicifugae Rhizoma, Cnidii Rhizoma, Angelicae Radix,
Poria, Processi Aconiti Radix, and Ephedrae Herba had
anti-inflammatory effects.
And Paeoniae Radix, Cimicifugae Rhizoma, Cnidii Rhizoma,
Angelicae Radix, and Processi Aconiti Radix had anodyne effect
(Toriizuka, 2003).
These crude drugs were included in HST, ORT, NYT, HET,
JTT, Kikyoto, KSS, TSS, and Keisikajutubuto (KJT).
Many of these formulae are rich in antioxidants. Dragland
et al. (2003) assessed the contribution of culinary and medicinal
herbs to the total dietary intake of antioxidants.
There are few effective treatment options for drug-induced
stomatitis, such as that associated with cancer chemotherapy.
However, HST has a preventive effect on stomatitis associated
with radiation therapy and chemotherapy.
Kono et al. reported that 13 of 14 patients (92.8%) aﬄicted
with chemotherapy-induced oral mucositis (COM) during
mFOLFOX6 or FOLFIRI treatment for metastasis of advanced
colorectal cancer showed significant improvement following a 1-
week topical treatment (3 times daily oral rinse) with HST, with
significantly decreased mean Common Terminology Criteria
for Adverse Events (CTCAE) grade (P = 0.0012) (Kono
et al., 2010). Aoyama et al. conducted a double-blind, placebo-
controlled, randomized study of HST for COM from gastric
cancer treatment. Although HST treatment did not reduce the
incidence of grade 2 or higher COM, a trend was observed in
whichHST reduced the risk of grade 1 COMduring the screening
cycle (Aoyama et al., 2014).
OGT significantly improves mucositis caused by anticancer
agents (Okumi and Koyama, 2014).
These studies suggest that the expression of stomatitis is
related to generation of reactive oxygen species (ROS) and that
antioxidants contained inmedicinal herbs can effectivelymitigate
this damage (Oka, 1995; Dragland et al., 2003; Horie et al.,
2008; Yamaguchi et al., 2008; Kono et al., 2010; Li et al., 2010;
Zheng et al., 2011; Aoyama et al., 2014). A list of antioxidants in
Chinese and Japanese medicinal herbs and products is presented
in Table 1. Antioxidant scores are from Dragland et al. (2003).
The Chinese and Japanese medicinal herbs Cinamomi Cortex,
Scutellariae Radix, and Paeoniae Radix contained >50mmol
antioxidants per 100 g, while Saikokeishito, JTT, and HET
contained 9.7–21.4mmol antioxidants per 100 g (Dragland et al.,
2003). Oka et al. conducted a randomized controlled trial on
the efficacy and safety of ORT for the treatment of 30 acute
aphthous stomatitis cases, and found faster resolution of pain in
the ORT extract group (4.5 g t.i.d.) (Oka, 1995). Yamaguchi et al.
described four cases of aphthous stomatitis treated with Kampo
medicine, three of which were treated with NYT, HET, and/or
TSS because of vital energy deficiency and/or blood circulatory
function deficiency, while the other case was treated with BNT
to mitigate an internal hot state associated with oral candidiasis.
Two or three months later, all cases were completely healed
(Yamaguchi et al., 2008).
Burning Mouth Syndrome (BMS),
Glossalgia (Glossodynia), and Atypical
Facial Pain (AFP)
BMS is characterized by chronic pain in the tongue or other oral
mucous membranes in the absence of any visible abnormality or
organic disease (Baker and Savage, 2005; Klasser et al., 2008, 2011;
Ferensztajn et al., 2013). Burning mouth patients typically exhibit
pain symptoms bilaterally in themouth, with themost commonly
affected sites being the tongue and lip. Glossalgia (glossodynia) is
a disease in which tongue pain occurs without abnormal findings
in the lingual mucosa. Characteristic features of glossalgia are
as follows. (1) It is common in women at a cancer-prone
age (middle-aged and older). Menopausal or postmenopausal
hormone changes, stress, anxiety, and nervousness are involved
in aggravation and continuation of symptoms. (2) It occurs
more frequently in the tip and lateral margins of the tongue but
infrequently at the back of the tongue. (3) The pain mitigates or
resolves on talking or eating (Yamaguchi, 2013). Both AFP and
atypical dental pain refer to chronic persistent pain in the oral
cavity, jaw, face, and/or teeth without identifiable organic causes.
However, these symptoms may be related to somatoform and
psychological factors because it is generally accepted that the pain
is independent of peripheral nerve activity (Yamaguchi, 2013).
In the International Classification of Headache Disorders II,
the International Headache Society categorizes BMS as cranial
neuralgias (International Headache Society, 2004). The etiology
of BMS is currently unknown; however, most studies support a
multifactorial syndrome involving the interaction of biological
and psychological factors (particularly paresthesia, altered taste
sensation, blood stasis, andmouth dryness due to the lack of fluid,
and depression) (Baker and Savage, 2005; Klasser et al., 2008,
2011; Ferensztajn et al., 2013; Yamaguchi, 2013).
Nerve System Related with BMS
BMS-associated changes in peripheral nerve function
Lauria et al. investigated the role of trigeminal small-fiber
sensory neuropathy in BMS. Patients showed a significantly
lower density of epithelial nerve fibers than controls and
remaining fibers were diffuse, reflecting axonal degeneration
(Lauria et al., 2005). Yilmaz et al. investigated the contribution
of the capsaicin receptor (transeint receptor potential vanilloid
receptor-1:TRPV1), which mediates heat-like oral pain, and
nerve growth factor (NGF) in BMS. There were fewer nerve fibers
penetrating the epithelium (p < 0.0001), again consistent with
small fiber neuropathy, while there was a significant increase
in TRPV1-positive fibers (p = 0.0011). Moreover, there was
a significant correlation between the baseline pain score and
expression of both TRPV1-positive (p = 0.0143) and NGF-
positive fibers (p = 0.0252), and patients were more sensitive
than controls to capsaicin-induced pain. Thus, selective TRPV1
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TABLE 1 | Antioxidants in Kampo medicine and crude drugs.
Crude drug (Antoxidant Kampo medicine
mmol/100 g)*
Oren Hange Shasin Sho Saiko Ninjin Youei Hochu Ekki Touki Shakuyaku Byakoka Ninjin
To (ORT) To (HST) To (SST) To (NYT) To (HET) San (TSS) To (BNT)
Glycyrrhiae Radix (11.6)*
Ginseng Radix (1.5)*
Zizyphi Fructus (5.9)*
Angelicae Radix (3.0)*
Pinelliae Tuber (0.3)*
Cinnamomi Cortex (120.2)*
Scutellariae Radix (111.5)*
Paeoniae Radix (55.1)*
Zingberis Rhizoma (7.5)*
Atractylodis Lanceae Rhizoma (7.4)*
Bupleuri Radix (5.7)*
Astragali Radix (4.9)*
Poria (Holelen) (2.8)*
Cimicifugae Rhizoma (64.3)*
Aurantii nobilis Pericarpium (17.5)*
Cnidii Rhizoma (6.7)*
Rhemanniae Radix (3.9)*
Indicate the contents of Kampo medicine.
*Antoxidant value (mmol/100 g) of crude drug.
and NGF blockers may provide a new therapy for BMS (Yilmaz
et al., 2007).
Central Pain Mechanisms of BMS
Capsaicin-induced TRPV1 receptor-mediated pain can induce
a distal analgesic effect (pain-induced analgesia) as evidenced
by elevated paw mechanical withdrawal threshold in rats
(Gear et al., 1999). This pain-induced analgesia was blocked
by pre-injection of a dopamine antagonist into the nucleus
accumbens, implicating the Central nerve system (CNS) in the
modulation of BMS-associated pain (Gear et al., 1999). Recently,
Jääskeläinen et al. and Hagelberg et al. reported changes in
putamenal/striatal dopamine receptor expression in patients
with BMS or AFP using positron emission tomography (PET)
imaging (Jääskeläinen et al., 2001; Hagelberg et al., 2003a,b,
2004). Increased binding of the D2 antagonist 11C-raclopride
and a concomitant decrease in the D1/D2 ratio may indicate
a decline in endogenous dopamine levels in the putamen
of BMS patients, suggesting that dysfunction of dopamine-
mediated central pain inhibition contributes to BMS (Hagelberg
et al., 2003b). Furthermore, Hagelberg et al. reported a similar
increase in D2 receptor availability and decrease in D1/D2
ratio in the putamen of patients with AFP, again suggesting
that the nigrostriatal dopaminergic system may be impaired in
chronic orofacial pain (Hagelberg et al., 2003a, 2004). In light
of these findings, the effects of several Kampo formulations,
including Saikokaryukotsuboreito (SRB), Yokukansan (YKS),
KSS, and Saibokuto (SBT), on the mesolimbic system have been
examined for efficacy against these orofacial pain disorders.
These formulae are broadly effective treatments for BMS,
glossalgia, atypical maxillofacial pain, and atypical dental pain
(Yamaguchi, 2013) as discussed below. Moreover, these agents
appear to suppress the psychological sequel of depression and
anxiety.
Effective Kampo Medicine for Psychogenic BMS
Saikokaryukotsuboreito (SRB)
Sasaki et al. found that preadministration of SRB (600mg/kg,
p.o.) suppressed the increase in amygdalar, hypothalamic,
and thalamic dopamine, and 3,4-dihydroxy-phenyl acetic
acid (DOPAC) in mice exposed to psychological stress and
conditioned fear, but not in mice subjected to electric shocks
(Sasaki et al., 1998). In addition, Mizoguchi et al. reported that
SRB ameliorated the stress-induced depressive state and reversed
the decrease in both extracellular serotonin and dopamine in the
prefrontal cortex (PFC). Thus, SRB may ameliorate the chronic
stress-induced depressive state by normalizing both cortical and
striatal dopamine (Mizoguchi et al., 2010).
Yokukansan (YKS)
Mizoguchi et al. reported anxiolytic effects of YKS in aged rats
as evidenced by increased open arm activity in the elevated plus
maze, and found that YKS reversed the age-related decreases
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in extracellular dopamine and serotonin within the aged PFC
(Mizoguchi et al., 2010).
Suzuki et al. reported suppression of mechanical and thermal
allodynia by YKS in the chronic constriction injury model
of chronic pain. In addition, YKS significantly reduced the
increase in cerebrospinal fluid glutamate induced by mechanical
or cold stimuli, while glutamate transporter inhibitors (DL-
threo-beta-hydroxy aspartate, and dihydrokainate) suppressed
these antiallodynic effects. Thus, YKS-induced antiallodynia in
rats appears to be mediated by reduced spinal glutamatergic
neurotransmission via enhanced glutamate transporter activity
(Suzuki et al., 2012). These reports (Sasaki et al., 1998; Mizoguchi
et al., 2010; Suzuki et al., 2012) indicate that herbal medicines
can reduce stress and associated pain by altering glutamatergic
and monoaminergic transmission in hypothalamus, amygdala,
PFC, and spinal cord. The clinical efficacy of KM for BMS
and AFP may depend on regulation of the mesolimbic
dopaminergic and descending glutamatergic pain modulation
systems.
Saibokuto (SBT)
SBT is effective for glossalgia (including laryngopharyngeal
discomfort) associated with fluid retention in the ShoYo stage
(the stage of disease transformation with heat halfway between
exterior and interior, characterized by bitter taste). Bessho et al.
compared the efficacy of SBT to tranquilizer plus vitamin B
complex combination therapy for patients with glossodynia.
Each of the subjective symptoms (pain, burning sensation,
and unpleasant feeling) was evaluated on a 10-point scale. It
was found that SBT reduced pain and burning sensation in
glossodynia patients more effectively than diazepam plus vitamin
B complex therapy. The majority of SBT-treated patients (92%)
reported good or excellent responses after 3 months compared to
only 69% in the diazepam group (Bessho et al., 1998).
St. John’s wort
It is also said that St. John’s wort is effective for depression.
Klasser studied the herbal supplement Hypericum perforatum
(St. John’s wort) for management of BMS as one of the systemic
medications (Klasser et al., 2011).
Cold/Heat with Microcirculation Disorder
For effective Kampo treatment, it is important to determine
whether the pain is due to cold/heat imbalance or to stagnation
of Ki, blood, and/or fluid. Chen et al. reported 18 cases of
glossodynia exhibiting a microcirculation disorder of the tongue
(Chen et al., 2000). Glossalgia in patients with a deficiency
pattern associated with vital energy depression can be treated
with HET, which improves quality of life and immunological
status of weakened postoperative patients by upregulating the
microcirculation.
Another treatment option is TSS, which is used for glossalgia
associated with general malaise, fatigue proneness, menstrual
disorder, palpitation, or autonomic nerve imbalance, particularly
in patients with “white fur tongue” and dark-red punctate color
change on the lingual tip andmargins. KSS is used for nonspecific
complaints and upper heat/lower cold in deficiency-pattern
patients. Redness at the tip of the tongue indicates upper-body
heat and is a good indication for this formula. Both TSS and KSS
improve the microcirculation.
Takayama et al. reported that TSS increases ocular blood flow
(OBF) in healthy subjects compared with control (p < 0.01) and
from 30 to 60min after administration compared with baseline
(p < 0.05) (Takayama et al., 2014). Goto examined the efficacy
of Kampo for blood stasis syndrome in Japan. There are many
signs of this syndrome, such as a dry mouth, fullness of the
abdomen, and rough skin. Patients with blood stasis syndrome
showed hemorheological abnormalities, and an improvement in
these abnormalities was found after administration of removing-
blood stasis formulae. Blood stasis syndrome is more than
just a circulatory deficiency; it encompasses the pathological
concept of constant multilateral change in the living body
(Goto, 2014).
Yamaguchi et al. reported that HET, TSS, and/or KSS reduced
visual analog scale (VAS) pain score by 92.4% after 19.4 weeks
in BMS patients (Yamaguchi et al., 2007). In addition, Yamaguchi
et al. reported a case of BMS treated with BNT, which reduced the
VAS score from 44mm to almost 0 after 18 weeks (Yamaguchi
et al., 2005). Thus, BNT is appropriate for patients with an
interior heat pattern associated with oral dryness; therefore, it
is effective, particularly for glossalgia associated with nocturnal
thirst. Kikyoto (KKT) is also effective as an anti-inflammatory
and heat pattern-treating (Seinetsu) formulation. Yamaguchi
et al. reported a case of glossodynia with erythrokeratoderma
treated with both internal and gargled KKT. After 6 weeks,
the VAS scale of glossodynia was reduced from 47 to 11 and
skin symptoms were also relieved. By 11 weeks of treatment,
glossodynia VAS was reduced by 85% and skin symptom VAS by
43% (Yamaguchi et al., 2009).
Kampo Theory and Herbal Constituents
Kampo theory encompasses Yin/Yo theory, Ki (vital energy),
Ketsu (blood), and Sui (fluid) theory, and five viscera theory.
Yin/Yo Theory
The Yin/Yo theory is based on the philosophical concept of well-
balanced pairs of complementary aspects, such as heaven and
earth or day and night. Medical, excess, heat, and Ki belong to
the Yo category, while deficiency, cold, blood, and fluid (visible
circulating element) belong to the Yin category (The Japan
Society for Oriental Medicine, 2005).
Ki·Ketsu·Sui Theory
Ki is invisible circulating vital energy and belongs to the Yo
category. Ki disturbance is manifested by regurgitation of Ki
and depression of Ki. Ketsu indicates blood (one of the visible
circulating elements) and belongs to the Yin category.
Ketsu disturbance is manifested by blood stasis (Oketsu) and
Ketsu deficiency.
Sui is fluid (one of the visible circulating elements) that
belongs to the Yin category. Sui disturbance is manifested by
accumulation of Sui and impaired water excretion (The Japan
Society for Oriental Medicine, 2005).
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Five Parenchymatous Viscera Theory
Five parenchymatous viscera (liver, heart, spleen, lung, and
kidney) are used as functional units in Kampo theory. The
concept of five parenchymatous viscera encompasses not only
the viscera of western medicine but also several differential
functional units. Every viscera produces Yin and Yo products. In
the abnormal stage, the deficiency or excess in Yin and/or Yo, or
a dual deficiency is observed in the body (The Japan Society for
Oriental Medicine, 2005).
Hijikata et al. recommended application of Kampo theory to
determine the appropriate herbal prescriptions for patients with
incurable glossodynia (Hijikata et al., 2008). KM used for patients
with incurable glossodynia are as follows: RKT, Jiinkokato,
Hachimijiogan, Ryutanshakanto, Seishoekkito, Bakumondoto
(BMT), Kamikihito, Chikujountanto, Rokumijiougan, KSS, and
Kambakutaisoto. KM, properly prescribed on the basis of Kampo
theory, quickly resolved the pain of refractory glossodynia
(Yamaguchi et al., 2009). Okamoto et al. reported that 69.2%
of glossodynia patients treated by Kampo responded well, with
an average delay to improvement of 8.0 ± 7.7 weeks. The
most common herbs in the aforementioned preparations for
glossodynia are Glycyrrhiza Root, Ginseng Root, Poria (Holelen),
and Atrctylodes (lancea) Rhizome, which together comprise
an essential Kampo prescription called Shikunshito. The two
most frequently used KM for glossodynia in patients showing
high response (reduction in severity of 50% or more) are
Seinetsuhokito and Mibakuekkito (Okamoto et al., 2003).
A summary of KM used for the treatment of BMS, glossalgia,
and AFP is presented in Table 2 (Bessho et al., 1998; Sasaki
et al., 1998; Okamoto et al., 2003; The Japan Society for Oriental
Medicine, 2005; Yamaguchi et al., 2005, 2007, 2009; Hijikata et al.,
2008; Mizoguchi et al., 2010; Suzuki et al., 2012; Yamaguchi,
2013). Themost effective constituent crude drugs are Glycyrrhiae
Radix, Atractylodis Lanceae Rhizoma, Angelicae Radix, Bupleuri
Radix, Ginseng Radix, Zingberis Rhizoma, and Poria (Holelen)
(Bessho et al., 1998; Sasaki et al., 1998; Okamoto et al., 2003; The
Japan Society for Oriental Medicine, 2005; Yamaguchi et al., 2005,
2007, 2009; Hijikata et al., 2008; Mizoguchi et al., 2010; Suzuki
et al., 2012; Yamaguchi, 2013) (Table 3).
Oral Cancer
The surgical remedy, chemotherapy, and radiotherapy are main
treatment strategy of oral cancer. From the standpoint of
providing mild therapy in cancer treatment, herbs and herbal
combinations have attracted a great deal of attention. In
conjunction with this phenomenon, the actions of many herbs
are now being examined at the pharmacologic and molecular
levels, suggesting that increased scientific understanding of
the actions of many traditional herbal remedies may identify
compounds with novel therapeutic uses. Several researchers and
oncologists have reported the direct inhibitory effects of herbs
or herbal combinations on the proliferation of cancer cells (Liao
et al., 2005; Yang et al., 2011). The main purpose of additive
kampo therapy in patients with oral cancer is to complement
the main anti-cancer therapy, to reduce side effect caused by the
TABLE 2 | Kampo medicines for BMS, glossalgia, and AFP.
Target and Kampo
medicine
Effect
1) Nervous system
Saikokaryukotuboreito
Ameliorates chronic stress-induced depressive state by
preventing prefrontal cortex dysfunction
1) Nervous system
Yokukansan
Antiallodynic effects in rats related to blockade of spinal
cord glutamatergic neurotransmission via activation of
glutamate transporters
1) Nervous system
Saibokuto
Improves glossodynia more effectively than diazepam
plus vitamin B complex
2) Hot/cold,
microcirculation
Hochuekkito
Improves symptoms of BMS by correcting “Ki deficiency”
2) Hot/cold,
microcirculation
Tokishakuyakusan
Improves the symptoms of BMS by correcting deficiency
of “Ketsu” and microcirculation
2) Hot/cold,
microcirculation
kamishouyousan
Improves “Yo” by correcting ”kidney Yin” and “liver Yin”
deficiency, as well as restless organ disorder based on
Yin deficiency of five viscera
2) Hot/cold,
microcirculation
Byakko-ka-ninjinto
Improves BMS symptoms such as dry mouth and
intraoral pain
2) Hot/cold
microcirculation
Kikyoto
Improves glossodynia and erythrokeratoderma
3) Kampo theory
Rikkunshito
Improves “spleen vital energy” and “heart Yin” deficiency,
stagnation of “liver Ki (vital energy) producing fire,” and
“gallbladder Ki (vital energy)” deficiency
3) Kampo theory
Jiinkokato,
Hachimijiogan,
Ryutanshakanto
Improves “spleen Yin” and “heart Yin” deficiency, “kidney
Yo” deficiency, and “liver Ki (vital energy)” stagnation
producing heart syndrome
3) Kampo theory
Seishoekkito,
Bakumondoto
Improves “spleen Ki (vital energy) “ deficiency and
“stomach Yin” deficiency producing heart syndrome
3) Kampo theory
Bakumondoto
Improves “spleen Ki” deficiency and “stomach Yin”
deficiency producing heart syndrome
3) Kampo theory
Kamikihito,
Chikujountanto
Improves “spleen Ki” and “heart Yin” deficiency,
stagnation of “liver Ki producing fire,” and “gallbladder
Ki” deficiency
3) Kampo theory
Rokumijiougan,
Kanbakutaisoto
Improves Yo rise based on “kidney Yin” and “liver Yin”
deficiency as well as restless organ disorder based on
Yin deficiency of five viscera
3) Kampo theory
Hangeshashinto,
Anchusan
Improves “spleen Yo” deficiency
3) Kampo theory
Mibakuekkito,
Seinetsuhokito
Improves glossodynia
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TABLE 3 | Frequently used Kampo medicines and the effective herbs for BMS, glossalgia, and atypical orofacial pain.
Effective crude drugs Medicines
Seinetu hokito Saibokuto Kami Shoyosan Mibaku Ekki To Hochu Ekki To Toki Shakuyaku San Yoku kan san
Glycyrrhiae Radix
Atractylodis Lanceae Rhizoma
Angelicae Radix
Bupleuri Radix
Ginseng Radix
Zingberis Rhizoma
Poria (Holelen)
Cimicifugae Rhizoma
Paeoniae Radix
Zizyphi Fructus
Astragali Radix
Pinelliae Tuber
Indicate the contents of Kampo medicine.
main anti-cancer therapy, and to improve quality of life such as
the overall status and/or oral discomfort. Taken together, I here
introduce four possible applications of KM to the treatment of
oral cancer.
Direct Inhibitory Effects of Herbs or Herbal
Combinations on the Proliferation of Cancer Cells
Liao et al. reported the induction of apoptosis in human
oral cancer cell lines by Chingwaysan (CWS), a Chinese
herbal medicine containing Cimicfugae Rhizoma, Rehmanniae
Radixet Rhizoma, Moutan Radicis Cortex, Coptidis Rhizoma,
and Angelicae Sinensis Radix, well known as an effective
treatment for intraoral ulcerative lesions and gingival bleeding.
CWS inhibited the proliferation of human OC2 and TSCCa
cells, accompanied by morphological changes, reduced cell
viability, and internucleosomal DNA fragmentation consistent
with apoptotic cell death. Furthermore, CWS induced a dose-
dependent increase in the proapoptotic Bax protein (Liao et al.,
2005).
Salvia miltiorrhiza (Danshen) has been used for treating
angina pectoris, myocardial infarction, and for improving blood
flow. Ya Yang et al. reported that salvianolic acid B (Sal B)
inhibited proliferation of two oral squamous cell carcinoma
(OSCC) cell lines, CAL27 and SCC4. Moreover, DNAmicroarray
analysis of genes involved in angiogenesis revealed 17 showing
a greater than three-fold change in expression. Among these,
hypoxia inducing factor-1α (HIF-1α), tumor necrosis fuctor- α
(TNFα), and matrix metalloproteinase-9 (MMP9) were inhibited
and expression of thrombospondin-2 (THBS2) was upregulated
(Yang et al., 2011).
Complementation of the Main Anti-cancer
Therapy
Satoh et al. found that HET increased lymphocyte cell-surface
antigens, CD3-positive cells, and CD3/CD4 double-positive cells
(p < 0.05) in elderly patients with chronic weakness, and this
increased immune function was associated with increased QOL
(Satoh et al., 2005).
Ikemoto et al. showed the immunoaugumentation effects
of JTT empirically considered an immunoaugumentation
drug, by investigating regulatory T cell (Treg) levels and
other immunological parameters in 30 patients with advanced
pancreatic cancer. Peripheral Foxp3+ Treg populations,
CD4/CD8 ratio, and CD57+ cell (natural killer, NK cell)
populations were estimated after 14 days of JTT administration
prior to anticancer therapy. Administration of JTT significantly
decreased Treg populations (P < 0.001) and increased the
CD4/CD8 ratio (P < 0.01), while CD57+ cell populations did
not significantly change (Ikemoto et al., 2014).
Matsuda et al. reported that oral administration of JTT
increases the production of Interleukin-12 (IL-12) in the lungs,
which is responsible for the activation of both NK and NKT cells,
resulting in inhibition of B16 melanoma cell metastasis (Matsuda
et al., 2011).
Reduction of Side Effect Caused by the Main
Anti-cancer Therapy
JTT include the crude drugs (Angelicae Radix, Paeoniae
Radix, Cnidii Rhizoma, and Rehmanniae Radix) with
the hematopoiesis. Therefore, JTT is used for anemia and
leukocytopenia as an adjuvant therapy.
Ogawa et al. evaluated the efficacy of JTT on alleviating
myelosuppression induced by TS-1 therapy inmice, and explored
biomarkers that reflect both bone marrow suppression by TS-
1 and alleviation by JTT using a proteomics approach. After
administration of TS-1, a significant decrease in White blood
cell (WBC) count and CD34+ bone marrow cells (BMC) ratio
were observed on days 5 and 3, respectively. JTT treatment
improved WBC count on day 7 and CD34+ BMC ratio on days
5 and 7. Surface-enhanced laser desorption analysis identified
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three protein peaks that increased on day 3 after treatment
with TS-1 but remained unchanged in mice cotreated with JTT
(Ogawa et al., 2012). This study indicates that bone marrow
suppression by TS-1 treatment in mice may be improved by
coadministration of JTT. A C-terminal fragment of albumin was
identified as a candidate biomarker for predicting TS-1-induced
myelosuppression.
Ohara et al. evaluated the clinical effects of HET and NYT in
patients with gastric cancer, colorectal cancer, breast cancer, and
other cancers undergoing tegafur chemotherapy in a randomized
controlled trial. In that study, loss of appetite was significantly
improved by HET, while nausea/vomiting, bowel movement
abnormalities, motivation, and fatigue/malaise were significantly
improved by NYT. Overall improvement was 36.8% for HET and
33.9% for NYT compared to only 14.3% for tegafur alone (Ohara
et al., 1993).
To control cancer pain that can result from the cancer itself,
complementation of KM is essential. Yamaguchi et al. (2002)
reported a case of tongue cancer with touch pain at meal time
successfully treated with RKS, NYT, and BNT. In that report
(Yamaguchi et al., 2002), Pain was well controlled and the general
condition improved during cancer treatment. RKS contains
several herbal essences that have local anesthetic and analgesic
effects. RKS was gargled 10min before meals and was effective
for 30–40min after rinsing. NYT proved useful for relaxation,
while BNT was used to reduce the symptoms of radiostomatitis
and xerostomia induced by radiotherapy. It is also known that
local temperature control (Cold, Hot) is important for pain
control (Yamaguchi et al., 2002). Yamaguchi et al. reported the
case of a 42-year-old male with chronic neuralgia-like pain,
following cyber knife therapy to treat recurrent mandibular
malignant fibrous histiocytoma, successfully treated with KJT.
In that report, VAS for pain decreased by 20% after 2 weeks
of treatment and was abolished after 4 weeks, with no reported
recurrence (Yamaguchi et al., 2011). Pain control was associated
with improved bilateral surface skin temperature.
Improve Quality of Life Such as the Overall
Status and/or Oral Discomfort
Takita et al. observed spontaneous regression of tongue cancer
in a 72-year-old terminal patient. JTT treatment (5 g/day) was
started without anticancer therapy, first orally and then by tube
feeding. Starvation gradually progressed. Tumor volumes both
in the oral cavity and neck gradually decreased, and bleeding
and pain were almost absent up to the terminal endpoint
(total inpatient period: 171 days). Moreover, the tumor had
almost disappeared on CT images acquired 5 h postmortem. The
progression to a comfortable natural death may have been aided
by spontaneous regression of the tumor (Takita et al., 2011).
Misumi et al. reported clinical effects of JTT in 16 oral cancer
patients. In the 10 group A members in whom treatment was not
indicated because of severity, palliative care was performed. The
course was frequently stable, with reduced cancer pain, and seven
of these patients did not require opioids. In contrast, in the 6-
group B members with multiple primaries or oral cavity cancer,
localized treatment was applicable, and the course was favorable
(Misumi et al., 2013).
JTT is an effective ancillary agent for those with age-, lifestyle-,
or treatment-related immunodeficiency due to oral cancer.
JJT inhibits the progression of liver tumors in a dose-
dependent manner and contributes to long-term survival, and
RKT contributes to the amelioration of anorectic conditions in
cancer cachexia-anorexia syndrome (Okumi and Koyama, 2014).
Yamaguchi et al. reported oral discomfort associated with
cancer treatment that were successfully treated with NYT. The
first was a 70-year-old female who complained of long-term
tongue pain at the right edge and multiple stomatitis. She had
a history of rectal cancer surgery at 33 and 39 years old, and was
hospitalized at age 69 for bowel dysfunction. Clinical diagnoses
were Candidal stomatitis and dry mouth. NYT 6 g/day was
applied, and an antifungal drug was used for gargling; symptoms
were almost absent after 4 months (Yamaguchi et al., 2012). A 68-
year-old male complained of xerostomia and multiple stomatitis
who had a history of prostate cancer surgery at 61 years and lung
cancer treatment at 62 and 63 years. Before Kampo treatment,
erosion of the mouth wing and dry tongue were noted, and the
Saxon test for saliva production yielded only 0.6 g/2min. NYT
9 g/day was applied and KKT gurgled. Two weeks later, parotid
saliva flow had improved, and after approximately 15 weeks of
treatment, dry mouth and stomatitis had abated (Yamaguchi
et al., 2012).
A summary of KM for cancer treatment is presented inTable 4
(Ohara et al., 1993; Yamaguchi et al., 2002, 2011, 2012; Liao et al.,
2005; Satoh et al., 2005; Matsuda et al., 2011; Takita et al., 2011;
Yang et al., 2011; Ogawa et al., 2012; Misumi et al., 2013; Ikemoto
et al., 2014; Okumi and Koyama, 2014).
Dry Mouth and Sjögren’s Syndrome
Dryness of the mouth may occur due to reduced saliva secretion
or as a sensation of dryness (thirst) in the presence of normal
saliva secretion. Prescriptions are selected according to the
condition of dryness (thirst or true dry mouth).
Thirst
Patients with this condition are constantly thirsty and tend
to drink copious amounts of water. The may also experience
frequent thirst at night and the desire to cool the mouth with
ice, either due to the presence of heat pattern (interior heat) or
fluid retention. BNT, Shosaikotokakikyosekko, Makyokansekito,
and KKT have heat-pattern-treating and saliva-secreting effects,
while Rokumigan and Hachimijiogan are effective for thirst due
to lower-region deficiency.
Dry Mouth
Other patients have dryness in the mouth but need moistening
of the oral cavity rather than water. This condition is associated
with dampness heat splashing sound, vital energy depression,
dual deficiency of vital energy and blood, and dryness and heat
due to lack of fluid. In addition to treating vital energy and fluid
deficiency, dry mouth can be effectively treated with NYT and
BMT, which possess heat-pattern-treating effects.
Miyazaki et al. reported that NYT improved oxybutynin
hydrochloride-induced xerostomia in 12 of 16 patients diagnosed
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TABLE 4 | Kampo medicine in cancer treatment.
Kampo medicine Effects of Kampo medicine
Chingwaysan
(CWS)
Effectively treats intraoral ulcerative lesions and
gingival bleeding
Inhibits proliferation and induces apoptosis of
tumor cells
Increases Bax expression
Danshen Inhibits OSCC proliferation
Inhibits angiogenesis by downregulating
multiple angiogenic genes
Ninjinyoeito (NYT) Reduces nausea/vomiting and bowel
movement abnormalities
Improves motivation and fatigue/malaise
Antioxidant effect
Rikko-san (RKS) Pain control via local anesthesia/analgesia
Antioxidant effect
Byakkokaninjinto
(BNT)
Useful for reducing symptoms of stomatitis and
xerostomia induced by radiotherapy.
Keishikajutsubuto
(KJT)
Improves radiation-induced neuralgia (cold
type)
Hochuekkito (HET) Improves immune function and appetite in
elderly patients
Antioxidant effect
Slows wasting and improves QOL.
Rikkunshito (RKT) Contributes to the amelioration of anorectic
conditions in cancer cachexia-anorexia
syndrome
Orengedokuto
(OGT)
Improves mucositis caused by anticancer
agents
Antioxidant effect
Juzentaihoto (JTT) May increase long-term survival
May induce spontaneous regression of tongue
cancer
Inhibits the progression of tumors
with psychogenic frequency or unstable bladder (chronic cystitis,
neurogenic bladder) (Miyazaki et al., 1994).
Yamaguchi et al. reported a case of xerostomia after oral cancer
treatment.
A 73-year-old female complained that lack of appetite and
dry mouth following radiation therapy (40Gy), TS-1 applied at
2240mg, and surgery for tongue cancer.
NYT 6 g/day was administered for treatment of tongue
pain, dry mouth, and anorexia. Two weeks later, appetite had
improved. Both dry mouth and appetite improved after 2
months of treatment (Yamaguchi et al., 2012). Yanagi et al.
reported that BNT ameliorated thirst in several rat thirst models
established by muscarinic receptor antagonists. This effect was
associated with increased expression of aquaporin 5, suggesting
that BNT enhanced salivary secretion by muscarinic (M3)
receptor-mediated upregulation of aquaporin 5. In fact, this
is one of several studies implicating changes in aquaporin
expression in the effects of Kampo therapy for dry mouth
(Yanagi et al., 2008). In contrast, Umemoto et al. reported
that the muscarinic agonist cevimeline hydrochloride hydrate
and histamine H2 receptor antagonist nizatidine, but not BMT,
significantly increased both basal and evoked salivary secretion
and relieved subjective symptoms of dry mouth (Umemoto
et al., 2007). However, Nishizawa et al. found BMT was effective
and safe for the relief of subjective symptoms and salivary
hyposecretion associated with primary SJS in four separate
randomized controlled trials (Nishizawa et al., 2002, 2003,
2004a,b). In fact, it was more effective and safer than the
mucolytic bromhexine hydrochloride. Ohno reported that 27 out
of 30 SJS patients in a quasi-randomized controlled trial showed
increased salivary secretion following Kampo treatment (12.0 ±
1.4ml vs. 8.2 ± 1.2ml at baseline; p < 0.005) (Ohno, 2006). KM
with moisturizing effects and associated studies are summarized
in Table 5 (Miyazaki et al., 1994; Nishizawa et al., 2002, 2003,
2004a,b; Ohno, 2006; Umemoto et al., 2007; Yanagi et al., 2008).
Crude Drug List
Kampo medicine consists of mineral, animal, and basidiomycete
as well as the crude drug of the plants.
The list of crude drug of the plants, species, family and main
KM in this article were described in Table 6.
The crude drugs were described in a lot of articles and species
were described in only three articles in this paper (Dragland et al.,
2003; Yanagi et al., 2008; Suzuki et al., 2012).
This search was carried out using “http://www.theplantlist.
org/, and http://mpns.kew.org/mpns-portal/”.
The crude drugs of mineral, animal and basidiomycota
were cited from “http://jpdb.nihs.go.jp/jp16e/” (The Japanese
Pharmacopoeia Sixteenth Edition, 2011) and
“http://wakankensaku.inm.u-toyama.ac.jp/wiki/Persist:
CrudeDrugList”.
The list of crude drug of mineral, animal and basidiomycota,
scientific names, family and main KM in this article were
described in Table 7.
Discussion
The human oral cavity is the initial digestive organ and is likely to
be affected by various local stimuli and microorganisms. And the
oral cavity is an anatomically complex structure that has evolved
to perform a multitude of functions
Therefore, it is necessary to use Kampo theory, such as Ki
(vital energy), Ketsu (blood), and Sui (fluid) abnormalities, to
treat oral diseases.
(1) In Kampo medicine, the treatment of stomatitis differs
depending on whether the symptoms are intense acute or
chronic. In acute stomatitis, heat because of agitated vital
energy may affect the head, chest, and middle abdominal region.
Therefore, treatment is required to cool the heat in the heart,
stomach, and liver using formulae with cooling effects. HST and
ORT cool the digestive organ. OGT calms irritation and cools
whole-body fever, and BNT controls physical fever and thirst and
provides moisture to the body.
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TABLE 5 | Kampo medicines to treat dry mouth and/or Sjögren’s syndrome.
Kampo medicine Disease, cases Study design Effect
Ninjinyoeito (NYT) Xerostomia induced by oxybutynin
(8 cases)
randomized clinical trial (RCT)
Human
effective
Byakkoka ninjinto (BNT) Increased the expression of aquaporin 5 in rat thirst models Rat effective
Bakumondoto (BMT) Dry mouth (excluding Sjögren’s syndrome, diabetes mellitus (DM) et al.)
100 cases
RCT
Human
not effective
Primary Sjögren’s syndrome
51 cases
RCT
Human
Effective
Primary Sjögren’s syndrome
115 cases (RCT)
RCT
Human
Effective
Secondary Sjögren’s syndrome
424 cases (RCT)
RCT
Human
Effective
Secondary Sjögren’s syndrome
380 cases (RCT)
RCT
Human
Effective
Secondary Sjögren’s syndrome
Hochuekkito (HET) Sjögren’s syndrome (28 cases) quasi- RCT
Human
Effective
Stomatitis is also related to the generation of ROS; therefore,
the antioxidant and anti-inflammatory activities of medicinal
herbs can be effective (Oka, 1995; Dragland et al., 2003; Horie
et al., 2008; Yamaguchi et al., 2008; Kono et al., 2010; Li
et al., 2010; Zheng et al., 2011; Aoyama et al., 2014). There
are numerous antioxidants in crude KM (Dragland et al., 2003)
(Table 1). HST is useful for stomatitis medicamentosa and
radiostomatitis (Kono et al., 2010; Aoyama et al., 2014). Thus,
we can control environmental factors (cold, heat, dampness,
dryness) and vital energy, blood, and fluid of the organ
systemically to treat stomatitis as well as reduce causative ROS.
(2) BMS, glossalgia, and AFP are chronic pain conditions
with no clear underlying pathology. Furthermore, these are
multifactorial syndromes involving the interaction of biological
and psychological factors (Baker and Savage, 2005; Klasser
et al., 2008, 2011; Ferensztajn et al., 2013; Yamaguchi, 2013).
Nonsteroid anti-inflammatory drugs (NSAIDs) are effective for
acute pain but are not very effective for chronic pain. The balance
of environmental factors (cold, heat, dampness, and dryness)
differs between acute and chronic pain (Yamaguchi, 2013). Local
temperature decrease and edema often occur in chronic pain.
These conditions result from local circulatory disturbances and
can be resolved by improving the flow of blood and fluid. Local
temperature decrease and edema are closely associated with
the balance of Ki (vital energy), Ketsu (blood), and Sui (fluid)
(Yamaguchi, 2013).
Glossalgia in patients with a deficiency pattern associated
with vital energy depression can be treated with HET, which
upregulates the microcirculation.
TSS not only controls the balance of blood and fluid but
also improves the peripheral circulation (Takayama et al., 2014).
KSS is used for nonspecific complaints and upper heat/lower
cold in deficiency-pattern patients. Both TSS and KSS improve
microcirculation and autonomic nerve imbalance.
Several reports investigated the contribution of the capsaicin
receptor TRPV1 (Gear et al., 1999; Yilmaz et al., 2007), which
mediates heat-like oral pain and NGF in BMS. RKS contains
crude Saisin, which has a chemical constitution resembles
capsaicin. RKS is thought to be effective against BMS caused by
the peripheral TRPV1 receptor.
Several KM, such as SRB (Mizoguchi et al., 2003), YKS
(Mizoguchi et al., 2010; Suzuki et al., 2012), KSS, and SBT
(Bessho et al., 1998), can reduce stress and associated pain by
altering glutamatergic and monoaminergic transmission in the
brain. These formulae are broadly effective treatments for BMS,
glossalgia, atypical maxillofacial pain, and atypical dental pain.
The clinical efficacy of KM for BMS and AFP may depend on
the regulation of the mesolimbic dopaminergic and descending
glutamatergic pain modulation systems. Moreover, these agents
appear to suppress the psychological sequel of depression and
anxiety (Tables 2, 3).
Oral Cancer
A deficiency of Ki, Ketsu, and Sui are present in oral cancer
patients. Kampo therapy is usually used as the adjuvant therapy,
side effect reduction and improvement of the overall status
and/or oral discomfort.
1. Inhibition of the proliferation of cancer cells: CWS effectively
treats intraoral ulcerative lesions and gingival bleeding,
inhibits tumor cell proliferation, and induces tumor cell
apoptosis (Liao et al., 2005).
2. Adjuvant therapy of the main cancer therapy: HET increased
lymphocyte cell-surface antigens, CD3-positive cells, and
CD3/CD4 double-positive cells in elderly patients (Satoh et al.,
2005). Administration of JTT significantly decreased Treg
populations and increased the CD4/CD8 ratio (Ikemoto et al.,
2014).
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TABLE 6 | The list of crude drugs, species, family, and main kampo medicines.
Crude drug Species and variety Family Main kampo medicines
Angelicae Radix Angelica acutiloba (Siebold & Zucc.) Kitagawa Apiaceae HET, JTT, KSS, NYT, TSS,
YKS
Anemarrhenae Rhizome Anemarrhena asphodeloides Bunge Asparagaceae BNT
Asiasari radix Asiasarum sieboldii F. Maekawa Aristolochiaceae RKS
Asarum sieboldii Miq.
Astragali Radix Astragalus membranaceus Bunge Leguminosae HET, JTT, NYT
Astragalus mongholicus Bunge, Mém. Acad. Imp. Sci. Saint
Pétersbourg
Atractylodis Lanceae Rhizoma Atractylodes lancea De Candolle. Asteraceae HET, JTT, KJT, KSS, NYT,
RKT, TSS, YKSAtractylodes lancea (Thunb.) DC.
Atractylodes japonica Koidzumi ex Kitamura
Aurantii nobilis Pericarpium Citrus deliciosa Ten Rutaceae HET, NYT, RKT
Bupleuri Radix Bupleurum falcatum Linné Apiaceae HET, KSS, SBT, SRB, SST,
YKS
Cimicifugae Rhizoma Actaea simplex (DC.) Wormsk. ex Prantl Ranunculaceae HET, RKS
Cinnamomi Cortex Cinnamomum cassia (L.) J.Presl Lauraceae JTT, KJT, NYT, ORT, SRB
Cinnamomum cassia (L.) J.Presl in F.Berchtold and J.S.Presl
Cnidii Rhizoma Cnidium officinale Makino Apiaceae JTT, TSS, YKS
Ligusticum officinale (Makino) Kitag
Gardeniae Fructus Gardenia jasminoides J.Ellis Rubiaceae KSS, OGT
Gentianae scabrae Radix Gentiana scabra Bunge Gentianaceae RKS
Ginseng Radix Panax ginseng C. A. Meyer Araliaceae BMT, BNT, HET, HST, JTT
NYT, ORT, RKT, SBT, SRB,
SST, YKS
Magnoliae Cortex Magnolia obovate Thunberg Magnoliaceae SBT
Magnolia officinalis Rehder and E.H.Wilson in C.S.Sargent
Menthae Herba Mentha canadensis Linné Lamiaceae KSS
Moutan Cortex Paeonia suffruticosa Andrews Paeoniaceae KSS
Ophiopogonis Tuber Ophiopogon japonicus (Thunb.) Ker Gawl. Asparagaceae BMT
Oryzae Fructus Oryza sativa Linné Poaceae BMT, BNT
Paeoniae Radix Paeonia suffruticosa Andrews Paeoniaceae JTT, KJT, KSS, NYT, TSS
Paeonia lactiflora Pallas
Perillae Herba Perilla frutescens (L.) Britton Lamiaceae SBT
Perilla frutescens var. crispa (Thunb.) H.Deane
Phellodendri Cortex Phellodendron amurense Ruprecht Rutaceae OGT
Phellodendron chinense C.K.Schneid.
Pinelliae Tuber Pinellia ternata (Thunb.) Makino Araceae BMT, HST, ORT, RKT, SBT,
SRB, SST
Platycodi Radix Platycodon grandiflorum A. De Candolle Campanulaceae KKT
Processi Aconiti Radix Aconitum japonicum Thunberg Ranunculaceae KJT
Aconitum carmichaelii Debeaux
Aconitum japonicum Thunb. in J.A.Murray
Rhemanniae Radix Rehmannia glutinosa (Gaertn.) DC. Plantaginaceae JTT, NYT
(Continued)
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TABLE 6 | Continued
Crude drug Species and variety Family Main kampo medicines
Saposhnikoviae Radix Saposhnikovia divaricata Schischkin Apiaceae RKS
Saposhnikovia divaricata (Turcz.) Schischk. in V.L.Komarov (ed.)
Uncariae
Uncis cum Ramulus
(Uncaria Hook)
Uncaria rhynchophylla (Miq.) Miq. ex Havil. Rubiaceae YKS
Uncaria sinensis (Oliv.) Havil., J. Linn. Soc.
Uncaria macrophylla Wall. in W. Roxburgh
Zingiberis Rhizoma Zingiber officinale Roscoe Zingiberaceae HET, HST, KJT, KSS, ORT,
RKT, SBT, SRB, SST
Zizyphi Fructus (Jujube) Zizyphus jujuba Miller var. inermis Rehder Rhamnaceae BMT, HET, HST, KJT, ORT,
RKT, SBT, SRB, SST
Ziziphus jujuba var. inermis (Bunge) Rehder
http://www.theplantlist.org/; http://mpns.kew.org/mpns-portal/
TABLE 7 | The list of Crude drugs of Mineral, Animal, Basidiomycota, and kampo medicines.
Crude drugs of mineral, animal, and Basidiomycota
Crude drug Scientific name Family Kampo medicines
Fossilia Ossis Mastodi (Longgu) Mineral (−) SRB
Gypsum Fibrosum Gypsum Mineral (−) BNT
Ostreae Testa (Oyster Shell) Ostrea gigas Thunberg Osteridae SRB
Poria Sclerotium Wolfiporia cocos Ryvarden et Gilberson Polyporaceae JTT, KSS, NYT, RKT, SBT, SRB, TSS, YKS
Poria cocos Wolf
http://jpdb.nihs.go.jp/jp16e/; http://wakankensaku.inm.u-toyama.ac.jp/wiki/Persist:CrudeDrugList
3. Side effect reduction of main anti-cancer therapy:Kampo
medicine is effective for symptom improvement during
oral cancer treatment, such as digestive symptoms,
impaired hematopoiesis, general malaise, and stomatitis
medicamentosa. Hozai, such as RKT, HET, JTT, and NYT,
content the crude drugs of the treatment of digestive
symptoms and blood formation. RKT and HET include
the effective crude drags of anorexia such as Atractylodis
Lanceae Rhizoma, Ginseng Radix, Zizyohi Fructus, and
Glycyrrhizae Radix. Also JJT and NYT include the effective
crude drags of anorexia such as Atractylodis (Lanceae)
Rhizoma, Ginseng Radix, Poria (Holelen) and Glycyrrhizae
Radix. Therefore, these KM are used for anorexia and general
malaise.
Furthermore, JJT include the crude drugs (Angelicae
Radix, Paeoniae Radix, Cnidii Rhizoma, and Rehmanniae
Radix) with the hematopoiesis. NYT include Angelicae Radix,
Paeoniae Radix, and Rehmanniae Radix. Therefore, these
KM are used for anemia and leukocytopenia as an adjuvant
therapy.
HET, JTT, and NYT also improve immune function (Satoh
et al., 2005; Takita et al., 2011; Ikemoto et al., 2014), digestive
symptoms, and general malaise in cancer patients (Misumi
et al., 2013; Okumi and Koyama, 2014).
4. Improvement of quality of life such as the overall status and/or
oral discomfort:
Those Hozai such as HET, JTT and NYT improve Ki, Ketsu,
and Sui deficiencies in cancer patients with palliative care.
Kampo formulae are useful for reducing the unpleasant side
effects of cancer therapy (Table 4).
(4) Heat- and cold-dryness stages exist in both dry mouth
and Sjögren’s syndromes.
The heat-dryness stage belongs to Yo and cold-dryness
stage belongs to Yin. BNT is useful for the heat-dryness
stage (Yo) (Yanagi et al., 2008) and NYT (Miyazaki et al.,
1994), BMT (Umemoto et al., 2007; Nishizawa et al., 2002,
2003, 2004a,b) and HET (Ohno, 2006) possess moisturizing
effects in the cold-dryness stage (Yin) (Table 5). In addition,
BMT and GRS affect aquaporin five expression, and thereby
improve salivation (Tsubota et al., 2001).
Conclusion
This article examined 54 studies and summarized
pharmacological actions and clinical applications of Japanese
herbal medicines in various refractory oral diseases such as
stomatitis, BMS, glossalgia, AFP, oral cancer, dry mouth, and SJS
from the standpoint of Kampo theory.
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These analyses are summarized in the Tables 1–5, and the list
of crude drugs, species, family, and main KM in this article were
described in Tables 6, 7.
Kampo therapy is useful for the treatment of oral
diseases that cannot be cured effectively by western
medicine.
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